Effect of initial immunosuppression on long-term kidney transplant outcome in immunological low-risk patients

Author(s):
Michielsen, L.A.; Zuilen, A.D. van; Verhaar, M.C.; Wisse, B.W.; Kamburova, E.G.; Joosten, I.; Allebes, W.A.; Meer, A. van der; Baas, M.C.; Spierings, E.; Hack, C.E.; Reekum, F.E. van; Bots, M.L.; Drop, A.C.A.D.; Plaisier, L.; Seelen, M.A.J.; Sanders, J.S.F.; Hepkema, B.G.; Lambeck, A.J.; Bungener, L.B.; Roozendaal, C.; Tilanus, M.G.J.; Voorter, C.E.; Wieten, L.; Duijnhoven, E.M. van; Gelens, M.A.C.J.; Christiaans, M.H.L.; Ittersum, F.J. van; Nurmohamed, S.A.; Lardy, N.M.; Swelsen, W.; Pant, K.A. van der; Weerd, N.C. van der; Berge, I.J.M. ten; Bemelman, F.J.; Hoitsma, A.; Boog, P.J.M. van der; Fijter, J.W. de; Betjes, M.G.H.; Heidt, S. (0000-0002-6700-188X); Roelen, D.L.; Claas, F.H.; Otten, H.G.; Hilbrands, L.B.
Published
2019
Publication type
Article / Letter to editor
anti-HLA antibodiesgraft survivalimmunological low-riskimmunosuppressionkidney transplantation
Date issued
2019-08-31
Language
English
Is part of
Nephrology Dialysis Transplantation (2019), Vol. 34, no. 8, p. 1417-1422
hdl
1887/121205
doi
10.1093/ndt/gfy377